1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Parkinson's Disease Revenue
1.4 Market Analysis by Type
1.4.1 Global Parkinson's Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Carbidopa/Levodopa
1.4.3 Dopamine Receptor Agonists
1.4.4 MAO-Inhibitors
1.5 Market by Application
1.5.1 Global Parkinson's Disease Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Parkinson's Disease Market
1.8.1 Global Parkinson's Disease Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Parkinson's Disease Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Parkinson's Disease Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Parkinson's Disease Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Parkinson's Disease Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Parkinson's Disease Sales Volume Market Share by Region (2015-2020)
3.2 Global Parkinson's Disease Sales Revenue Market Share by Region (2015-2020)
3.3 North America Parkinson's Disease Sales Volume
3.3.1 North America Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.3.2 North America Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Parkinson's Disease Sales Volume
3.4.1 East Asia Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Parkinson's Disease Sales Volume (2015-2020)
3.5.1 Europe Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Parkinson's Disease Sales Volume (2015-2020)
3.6.1 South Asia Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Parkinson's Disease Sales Volume (2015-2020)
3.7.1 Southeast Asia Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Parkinson's Disease Sales Volume (2015-2020)
3.8.1 Middle East Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Parkinson's Disease Sales Volume (2015-2020)
3.9.1 Africa Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Parkinson's Disease Sales Volume (2015-2020)
3.10.1 Oceania Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Parkinson's Disease Sales Volume (2015-2020)
3.11.1 South America Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.11.2 South America Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Parkinson's Disease Sales Volume (2015-2020)
3.12.1 Rest of the World Parkinson's Disease Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Parkinson's Disease Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Parkinson's Disease Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Parkinson's Disease Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Parkinson's Disease Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Parkinson's Disease Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Parkinson's Disease Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Parkinson's Disease Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Parkinson's Disease Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Parkinson's Disease Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Parkinson's Disease Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Parkinson's Disease Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Parkinson's Disease Sales Volume Market Share by Type (2015-2020)
14.2 Global Parkinson's Disease Sales Revenue Market Share by Type (2015-2020)
14.3 Global Parkinson's Disease Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Parkinson's Disease Consumption Volume by Application (2015-2020)
15.2 Global Parkinson's Disease Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Parkinson's Disease Business
16.1 Teva
16.1.1 Teva Company Profile
16.1.2 Teva Parkinson's Disease Product Specification
16.1.3 Teva Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Lundbeck
16.2.1 Lundbeck Company Profile
16.2.2 Lundbeck Parkinson's Disease Product Specification
16.2.3 Lundbeck Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 AbbVie
16.3.1 AbbVie Company Profile
16.3.2 AbbVie Parkinson's Disease Product Specification
16.3.3 AbbVie Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Novartis
16.4.1 Novartis Company Profile
16.4.2 Novartis Parkinson's Disease Product Specification
16.4.3 Novartis Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Amneal + Impax
16.5.1 Amneal + Impax Company Profile
16.5.2 Amneal + Impax Parkinson's Disease Product Specification
16.5.3 Amneal + Impax Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 GSK
16.6.1 GSK Company Profile
16.6.2 GSK Parkinson's Disease Product Specification
16.6.3 GSK Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Wockhardt
16.7.1 Wockhardt Company Profile
16.7.2 Wockhardt Parkinson's Disease Product Specification
16.7.3 Wockhardt Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Boehringer Ingelheim
16.8.1 Boehringer Ingelheim Company Profile
16.8.2 Boehringer Ingelheim Parkinson's Disease Product Specification
16.8.3 Boehringer Ingelheim Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Merck
16.9.1 Merck Company Profile
16.9.2 Merck Parkinson's Disease Product Specification
16.9.3 Merck Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Sun Pharma
16.10.1 Sun Pharma Company Profile
16.10.2 Sun Pharma Parkinson's Disease Product Specification
16.10.3 Sun Pharma Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 UCB
16.11.1 UCB Company Profile
16.11.2 UCB Parkinson's Disease Product Specification
16.11.3 UCB Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Bausch Health
16.12.1 Bausch Health Company Profile
16.12.2 Bausch Health Parkinson's Disease Product Specification
16.12.3 Bausch Health Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Acadia
16.13.1 Acadia Company Profile
16.13.2 Acadia Parkinson's Disease Product Specification
16.13.3 Acadia Parkinson's Disease Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Parkinson's Disease Manufacturing Cost Analysis
17.1 Parkinson's Disease Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Parkinson's Disease
17.4 Parkinson's Disease Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Parkinson's Disease Distributors List
18.3 Parkinson's Disease Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Parkinson's Disease (2021-2026)
20.2 Global Forecasted Revenue of Parkinson's Disease (2021-2026)
20.3 Global Forecasted Price of Parkinson's Disease (2015-2026)
20.4 Global Forecasted Production of Parkinson's Disease by Region (2021-2026)
20.4.1 North America Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.3 Europe Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.7 Africa Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.9 South America Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Parkinson's Disease Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Parkinson's Disease by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Parkinson's Disease by Country
21.2 East Asia Market Forecasted Consumption of Parkinson's Disease by Country
21.3 Europe Market Forecasted Consumption of Parkinson's Disease by Countriy
21.4 South Asia Forecasted Consumption of Parkinson's Disease by Country
21.5 Southeast Asia Forecasted Consumption of Parkinson's Disease by Country
21.6 Middle East Forecasted Consumption of Parkinson's Disease by Country
21.7 Africa Forecasted Consumption of Parkinson's Disease by Country
21.8 Oceania Forecasted Consumption of Parkinson's Disease by Country
21.9 South America Forecasted Consumption of Parkinson's Disease by Country
21.10 Rest of the world Forecasted Consumption of Parkinson's Disease by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer